Yonsei University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Yonsei University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11527
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yonsei University (Yonsei) is an educational service provider that offers training and research services. The university offers graduation programs in various areas such as applied statistics, architectural engineering, Asian studies, astronomy, atmospheric sciences, biochemistry, bio convergence, biological science and technology, biology, biomedical engineering, chemical engineering, chemistry, chemistry and biochemistry, child and family studies and Chinese language and literature, among others. Its research centers include biochip research center, biometrics engineering research center and cancer metasis research center, among others. The university operates in Seodaemun and Seoul. Yonsei is located in Seoul, South Korea.

Yonsei University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yonsei University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yonsei University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yonsei University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yonsei University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Yonsei University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Yonsei University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Celltrion Enters into Co- Development Agreement with Yonsei University 10
Infectious Disease Research Institute and Yonsei University Medical Center Form Joint Venture 11
Licensing Agreements 12
Amtixbio Receives Antifungal Therapy Technology from Yonsei University and Korea Institute of Science and Technology 12
Obetat Biopharma Enters into Licensing Agreement with Younsei University 13
Yonsei University – Key Competitors 14
Yonsei University – Key Employees 15
Yonsei University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Yonsei University, Pharmaceuticals & Healthcare, Key Facts 2
Yonsei University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yonsei University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yonsei University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yonsei University, Deals By Therapy Area, 2012 to YTD 2018 8
Yonsei University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Celltrion Enters into Co- Development Agreement with Yonsei University 10
Infectious Disease Research Institute and Yonsei University Medical Center Form Joint Venture 11
Amtixbio Receives Antifungal Therapy Technology from Yonsei University and Korea Institute of Science and Technology 12
Obetat Biopharma Enters into Licensing Agreement with Younsei University 13
Yonsei University, Key Competitors 14
Yonsei University, Key Employees 15
Yonsei University, Other Locations 16
Yonsei University, Subsidiaries 16

List of Figures
Yonsei University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Yonsei University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Yonsei University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Yonsei University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Yonsei University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yonsei University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Yonsei University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yonsei University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Yonsei University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shoppers Drug Mart Corporation:企業の戦略・SWOT・財務情報
    Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report Summary Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Posco Daewoo Corporation (047050)-石油・ガス分野:企業M&A・提携分析
    Summary Posco Daewoo Corporation (Posco Daewoo), formally known as Daewoo International Corporation, is an international trading and investment company. It is involved in international trade, resource development and project organizing businesses. The company’s operational activities include export …
  • MedicPen AB (MPEN):医療機器:M&Aディール及び事業提携情報
    Summary MedicPen AB (MedicPen) is a drug development company that manufactures, develops, and markets patented products. The company’s products include Medimi Pro and Medimi Smart. It also provides Medimi – MedicPen’s system for medication assistance. MedicPen offers automatic filling units for home …
  • Teleplan International NV:企業の戦略的SWOT分析
    Teleplan International NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Carl Zeiss Meditec AG (AFX):企業の財務・戦略的SWOT分析
    Carl Zeiss Meditec AG (AFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Inretail Peru Corp.:企業の戦略的SWOT分析
    Inretail Peru Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Neusoft Corporation (600718):企業の財務・戦略的SWOT分析
    Neusoft Corporation (600718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Dole Food Company Inc:企業のM&A・事業提携・投資動向
    Dole Food Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dole Food Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Arno Therapeutics Inc (ARNI)-医療機器分野:企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • Gujarat Sidhee Cement Ltd.:企業の戦略・SWOT・財務情報
    Gujarat Sidhee Cement Ltd. - Strategy, SWOT and Corporate Finance Report Summary Gujarat Sidhee Cement Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cargotec Oyj:企業のM&A・事業提携・投資動向
    Cargotec Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cargotec Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • IPCA Laboratories Ltd (IPCALAB):企業の財務・戦略的SWOT分析
    Summary IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company’s active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmin …
  • Kazia Therapeutics Ltd (KZA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kazia Therapeutics Limited (Kazia Therapeutics), is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on three drug technology platforms, phosphoinositide 3-kinase (PI3K) inhibitors, anti-tropomyosins (A …
  • PNE Wind AG (PNE3):電力:M&Aディール及び事業提携情報
    Summary PNE Wind AG (PNE) is a renewable energy company, which develops onshore and offshore wind farms. It has a presence in the wind energy value chain, from site exploration and implementation of approval procedure, financing and turnkey construction to operation and repowering. The company also …
  • Northern Ireland Electricity Networks Ltd:企業の戦略的SWOT分析
    Northern Ireland Electricity Networks Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • OriGene Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and markets genome research and diagnostic products. OriGene provides products such as qPCR r …
  • Breakthru Beverage Group, LLC:企業の戦略・SWOT・財務情報
    Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Bone Therapeutics SA (BOTHE):医療機器:M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • BioStar Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆